Gastrointestinal Dysfunction in Children Affected With Mitochondrial Disorders
Assessment and Prevalence of Gastrointestinal Dysfunction in Children With Mitochondrial Disorders (MD)
1 other identifier
observational
26
1 country
1
Brief Summary
Hypothesis: Many patients with underlying mitochondrial disorders have feeding problems because of poor gastrointestinal motility; feeding problems lead to growth impairment and many affected children are malnourished.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started Jun 2010
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 1, 2010
CompletedFirst Submitted
Initial submission to the registry
June 2, 2010
CompletedFirst Posted
Study publicly available on registry
June 4, 2010
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 1, 2011
CompletedStudy Completion
Last participant's last visit for all outcomes
March 1, 2011
CompletedFebruary 27, 2012
February 1, 2012
9 months
June 2, 2010
February 24, 2012
Conditions
Keywords
Study Arms (1)
Children with mitochondrial disorders
suffering from gastrointestinal dysfunction
Interventions
subjects will eat a solid meal (scrambled eggs, etc) or drink liquid (water or juice) mixed with approximately 0.5 millicuries of radioactive material. A scanner/external gamma camera will be placed over the subject's stomach at 15 minute intervals for a duration of 90 minutes (monitoring the amount of radioactivity in the stomach). As the radioactively-labeled food empties from the stomach, the amount of radioactivity in the stomach decreases. The rate at which the radioactivity leaves the stomach reflects the rate at which food is emptying from the stomach. The radioisotope has a half life of approximately. 6 hours and is totally eliminated from the body within 24 hours. In subjects with gastroparesis, the food and the attached radioactive material remain in the stomach longer than normal (usually hours) before emptying into the small intestine. As a result, the scanner continues to show radioactivity in the area of the stomach for hours after the test meal.
Eligibility Criteria
children suffering form mitochondrial disorders.
You may qualify if:
- Parents/Guardians are informed and given written consent.
- Subject is willing and able to comply with all trial requirements
- Subject is over 3 years of age.
- Subject has a diagnosis of mitochondrial disorder validated by the modified Walker criteria used for diagnosis of mitochondrial diseases(9).
- A female subject in the age group of 11 yrs. or older is not pregnant as evidenced by a negative urine dipstick pregnancy test
- Subject to be enrolled has one or more of the following gastrointestinal signs and symptoms pertaining to gastrointestinal dysfunction like but not limited to abdominal pain, nausea, vomiting, bloating, indigestion, abdominal distention or sense of abdominal fullness.
You may not qualify if:
- Subject is currently having one or more gastrointestinal disease/disorder that is not explained by the current knowledge of mitochondrial diseases. For example, patients suffering from peptic ulcer disease or inflammatory bowel diseases will be excluded.
- Subject is a pregnant or a nursing female.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University of Texas- Houston Health Sceince Center
Houston, Texas, 77030, United States
Related Publications (3)
Koenig MK. Presentation and diagnosis of mitochondrial disorders in children. Pediatr Neurol. 2008 May;38(5):305-13. doi: 10.1016/j.pediatrneurol.2007.12.001.
PMID: 18410845BACKGROUNDGillis LA, Sokol RJ. Gastrointestinal manifestations of mitochondrial disease. Gastroenterol Clin North Am. 2003 Sep;32(3):789-817, v. doi: 10.1016/s0889-8553(03)00052-9.
PMID: 14562575BACKGROUNDNissenkorn A, Zeharia A, Lev D, Fatal-Valevski A, Barash V, Gutman A, Harel S, Lerman-Sagie T. Multiple presentation of mitochondrial disorders. Arch Dis Child. 1999 Sep;81(3):209-14. doi: 10.1136/adc.81.3.209.
PMID: 10451392BACKGROUND
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Jatinder Bhardwaj, MD
Privat Practice - Toledo, OH
- PRINCIPAL INVESTIGATOR
Mary K Koenig, MD
The University of Texas Medical School at Houston
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assistant Professor - Pediatrics
Study Record Dates
First Submitted
June 2, 2010
First Posted
June 4, 2010
Study Start
June 1, 2010
Primary Completion
March 1, 2011
Study Completion
March 1, 2011
Last Updated
February 27, 2012
Record last verified: 2012-02